Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Study
0
Authors
Ian Glaspole
Ian Glaspole•David Baratz•Sergio Harari
Published
June 6, 2024
Abstract
Idiopathic pulmonary fibrosis (IPF) is a rare and progressive disease that causes progressive cough, exertional dyspnea, impaired quality of life, and death.